Terms: = Head and neck cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Clinical Outcome
3 results:
1. Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib.
Cipriani NA; Blair EA; Finkle J; Kraninger JL; Straus CM; Villaflor VM; Ginat DT
Int J Surg Pathol; 2017 Oct; 25(7):613-618. PubMed ID: 28497708
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands.
Chiosea SI; Griffith C; Assaad A; Seethala RR
Histopathology; 2012 Sep; 61(3):387-94. PubMed ID: 22372712
[TBL] [Abstract] [Full Text] [Related]
3. The prevalence of RET/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors.
Erdoğan M; Berdeli A; Karadeniz M; Ertan Y; Cetinkalp S; Saygili F; Tuncyurek M; Yilmaz C; Tuzun M; Kabalak T; Uluer H; Ozgen AG
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):225-30. PubMed ID: 18393128
[TBL] [Abstract] [Full Text] [Related]
